MoneyTrac Technology, Inc. has successfully sold the front cover of PotSaver’s premier Los Angeles edition, which is slated for release and mass distribution on January 1, 2018.
Cannabis News
Canopy Growth and Constellation finalize previously announced strategic transaction
Canopy Growth Corporation (TSX:WEED) has completed the previously announced transaction that saw Constellation Brands (NYSE: STZ and STZ.B) strategically invest CDN $245 million in Canopy Growth in exchange for 9.9% equity in the Company
Cannabis Wheaton Income Corp. Enhances Strategic Flexibility With Acquisition of Licensed Producer RockGarden Medicinals
The Acquisition furthers the Company's streaming platform strategy by providing the Company additional resources and regulatory tools to help accelerate Wheaton Licensing Program participants' pathway to licensing under the Access to Cannabis for Medical Purposes Regulations.
Is InMed Pharmaceuticals (OTCQB:IMLFF) The Next Big Thing In Cannabis?
Financials Trend thinks that InMed is a "four-bagger" of an investment thanks to proven expertise, a proprietary cutting-edge technology and TWO drugs already heading towards clinical trials that could quickly position InMed as a major player.
Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery
Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils.
CannTrust™ Announces $15 Million Bought Deal
CannTrust Holdings enters into an agreement with a syndicate of Underwriters to purchase, on a deal bought basis, 3,000,000 common shares of the company at a price of $5 per Common Share.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Receives Extensive Patent Allowance from USPTO
Lexaria Bioscience Corp. announced late yesterday that it has received a new Notice of Allowance from the USPTO related to the use of its innovative DehydraTECH™ technology.
ChineseInvestors.com, Inc. (CIIX) Announces Three Additions to Board of Directors
Market analysis company ChineseInvestors.com, Inc. this morning expanded its board of directors, announcing its appointment of Delray Wannemacher and Patrick Leung as independent directors and Keevin Gillespie as an executive director, effective immediately.
Canopy Growth adds to strategic content & branding prowess by adding Ted Chung & Dave Bigioni to key roles
Canopy Growth Corporation (TSX: WEED) today announced that it has welcomed the founder of Stampede Management, Ted Chung, as a Strategic Advisor for Content Strategy to strengthen and leverage responsible brand opportunities for Tweed and other cannabis brands in the lead-up to the legal adult-use market in Canada.
Leading Seed-to-Sale Payment Hub PayQwick Raises $2.86M to Support Expansion
PayQwick Inc., the leader in seed-to-sale electronic payment hub for the legal marijuana industry, today announced it has raised $2.86 million. PayQwick will use the funding to accelerate sales and product development as the company expands into California, Nevada, Michigan and Alaska.
EVIO, Inc. (EVIO) Expands Testing Capabilities at Yuba City Laboratory
EVIO, Inc. this morning announced that it has expanded testing capabilities at its Yuba City laboratory in Northern California.
Global Payout, Inc. (GOHE) Subsidiary Co-Hosts Cannabis Industry Networking Event
Global Payout, Inc. this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., successfully hosted a joint networking event last week in Las Vegas with fellow companies operating in the cannabis financial market sector.
New Cannabinoid Medicine Can Be Successfully Administered Via a Topical Gel Eye Lens
New cannabinoid medicine can be successfully administered via a topical gel lens into the eye, a new InMed-University of British Columbia study reports.
Biosynthetic cannabinoids could be the way of the future
InMed Pharmaceuticals develops technology to bridge the gap between synthetic and natural cannabinoids.
INMED PHARMACEUTICALS (CSE: IN; OTCMKTS: IMLFF) Could Be Poised For Gains
InMed Pharmaceuticals is a turnaround stock, with recent news updates showing promise for future gains